NCT03927079View on ClinicalTrials.gov

Predictive Factors of Good Pulmonary Penetration of Antibiotics : AntiBiotics Dosage in Broncho-Alveolar Lavage

NAActive, not recruitingINTERVENTIONAL
Enrollment

101

Participants

Timeline

Start Date

April 23, 2019

Primary Completion Date

April 1, 2022

Study Completion Date

June 1, 2026

Conditions
AntibioticsPneumonia
Interventions
BIOLOGICAL

measure of intra-alveolar antibiotic concentration in µg/ml

included patients will have a broncho-alveolar lavage (BAL) to measure intra-alveolar antibiotic concentration, and a blood test to measure plasmatic concentration

PROCEDURE

broncho-alveolar lavage (BAL)

included patients will have a broncho-alveolar lavage (BAL) to measure intra-alveolar antibiotic concentration, and a blood test to measure plasmatic concentration

BIOLOGICAL

blood test to measure plasmatic antibiotic concentration in µg/ml

included patients will have a broncho-alveolar lavage (BAL) to measure intra-alveolar antibiotic concentration, and a blood test to measure plasmatic

Trial Locations (1)

80480

CHU Amiens, Amiens

All Listed Sponsors
lead

Centre Hospitalier Universitaire, Amiens

OTHER

NCT03927079 - Predictive Factors of Good Pulmonary Penetration of Antibiotics : AntiBiotics Dosage in Broncho-Alveolar Lavage | Biotech Hunter | Biotech Hunter